Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients

BACKGROUND: In 2019, more than 30 % of all newly transplanted kidney transplant recipients in The Netherlands were above 65 years of age. Elderly patients are less prone to rejection, and death censored graft loss is less frequent compared to younger recipients. Elderly recipients do have increased...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Main Authors: de Boer, S. E., Sanders, J. S.F., Bemelman, F. J., Betjes, M. G.H., Burgerhof, J. G.M., Hilbrands, L., Kuypers, D., van Munster, B. C., Nurmohamed, S. A., de Vries, A. P.J., van Zuilen, A. D., Hesselink, D. A., Berger, S. P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172178/
https://ncbi.nlm.nih.gov/pubmed/34078323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02409-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados